Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-01-06
1995-10-03
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142378, 514311, 514331, 514332, 514341, 514365, 514396, 514406, 514432, 514445, 514451, 514602, 514604, 544168, 546175, 546247, 546265, 546276, 546336, 546337, 548205, 5483351, 5483381, 549 13, 549 65, 549426, 564 84, 564 90, 564 92, 564 94, C07D21342, A61K 3144
Patent
active
054552583
ABSTRACT:
Particularly the invention relates to the compounds of formula I ##STR1## (a) wherein Ar is carbocyclic or heterocyclic aryl;
R is hydrogen, lower alkyl, carbocyclic aryl-lower alkyl, carbocyclic aryl, heterocyclic aryl, biaryl, biaryl-lower alkyl, heterocyclic aryl-lower alkyl, mono- or poly-halo-lower alkyl, C.sub.3 -C.sub.7 -cycloalkyl, C.sub.3 -C.sub.7 -cycloalkyl-lower alkyl, hydroxy-lower alkyl, acyloxy-lower alkyl, lower alkoxy-lower alkyl, lower alkyl-(thio, sulfinyl or sulfonyl)-lower alkyl, amino, mono- or di-lower alkylamino)-lower alkyl, acylamino-lower alkyl, (N-lower alkyl-piperazino or N-aryl-lower alkylpiperazino)-lower alkyl, or (morpholino, thiomorpholino, piperidino, pyrrolidino, piperidyl or N-lower alkylpiperidyl)-lower alkyl;
R.sub.1 is hydrogen, lower alkyl, carbocyclic aryl-lower alkyl, carbocyclic aryl, heterocyclic aryl, biaryl, biaryl-lower alkyl, heterocyclic aryl-lower alkyl, mono- or poly-halo-lower alkyl, C.sub.3 -C.sub.7 -cycloalkyl, C.sub.3 -C.sub.7 -cycloalkyl-lower alkyl, hydroxy-lower alkyl, acyloxy-lower alkyl, lower alkoxy-lower alkyl, (carbocyclic or heterocyclic aryl)-lower alkoxy-lower alkyl, lower alkyl-(thio, sulfinyl or sulfonyl)-lower alkyl, (amino, mono- or di-lower alkylamino)-lower alkyl, (N-lower alkyl-piperazino or N-aryl-lower alkylpiperazino)-lower alkyl, (morpholino, thiomorpholino, piperidino, pyrrolidino, piperidyl or N-lower alkylpiperidyl)-lower alkyl, acylamino-lower alkyl, piperidyl or N-lower alkylpiperidyl;
R.sub.2 is hydrogen or lower alkyl;
pharmaceutically acceptable prodrug derivatives; and pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 4743587 (1988-05-01), Dickens et al.
patent: 4885027 (1989-12-01), Pomidor
patent: 4996358 (1991-02-01), Handa et al.
patent: 5114953 (1992-05-01), Galardy et al.
patent: 5137914 (1992-08-01), Ohtani et al.
patent: 5240958 (1993-08-01), Campion et al.
Chemical Abstracts, vol. 59, No. 3, Abstract 3824b, Aug. 5, 1963.
Trends Biotechnol., vol. 10, No. 6, 1992, pp. 200-207.
BioEssays, vol. 14, No. 7--Jul. 1992, pp. 455-463.
Annual Reports in Medicinal Chemistry, 25, pp. 177-184, 1989.
J. Med. Chem., 1989, 32, 145-151.
Synthesis, 1985, 929-931.
Chemical Abstract 93:81521r, 1980.
Chemical Abstract 59, 3824a (1963).
Microchemical Journal, 40, 226-232 (1989).
Chemical Abstract 70:88228j, 1959.
MacPherson Lawrence J.
Parker David T.
Ciba-Geigy Corporation
Davis Zinna N.
Gruenfeld Norbert
Ivy C. Warren
LandOfFree
Arylsulfonamido-substituted hydroxamic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylsulfonamido-substituted hydroxamic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylsulfonamido-substituted hydroxamic acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1077697